arrow
I

Isabelle Mahé

Paris Cite University
H指数:41
被引数:6,266

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Factors Associated With Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis

癌症相关血栓患者在延长阿哌沙班治疗期间复发性静脉血栓栓塞的相关因素

2026-10-170
OA
Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial

癌症相关静脉血栓栓塞症延长抗凝治疗期间临床相关出血的预测因素(API-CAT):一项随机、非劣效性试验的事后分析

2025-12-060
PRE
The Ottawa score for prediction of recurrent venous thromboembolism in cancer patients treated with tinzaparin: an individual patient data meta-analysis

奥塔瓦评分对接受那曲肝素治疗的癌症患者复发性静脉血栓栓塞症预测:一项基于个体患者数据的meta分析

2025-12-020
OAAI
The management of cancer-associated thromboembolism: Proposals from the French multidisciplinary INNOVTE CAT Working Group

癌症相关血栓栓塞的管理:法国多学科INNOVTE CAT工作组提案

2025-12-010
OAAI
Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling Study

替扎帕林在癌症患者中的药代动力学:一项比较模型研究

2025-11-010
PRE
Anti-thrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: A cohort study using population-linked routinely collected data

癌症终末期患者抗血栓治疗及其相关临床结局:一项基于人口关联常规收集数据的队列研究

2025-09-010
OAAI
“Who am I to say that I'm not going to take it”: patient perspectives on decisions about antithrombotic therapy in the context of advanced cancer

“谁有资格说我不会接受它”:在晚期癌症背景下关于抗凝治疗决策的患者视角

2025-07-060
PRE
Quality of vitamin K antagonist treatment during the last year of life

生命最后一年维生素k拮抗剂治疗的质量

2025-05-190
OA
Occult cancer in patients with unprovoked venous thromboembolism: Rationale, design, and methods of the VaLRIETEs study and the SOME-RIETE trial
2025-02-010
PRE
Extended Treatment of Venous Thromboembolism with Reduced- Vs Full-Dose Direct Oral Anticoagulants in Patients at High Risk of Recurrence

静脉血栓栓塞症的延长治疗:高风险复发患者中减量与标准剂量直接口服抗凝剂的应用比较

BLOOD
IF23.1
2024-11-250
PRE